Lv Chenrui, Guo Wenqiang, Yin Xinyi, Liu Liu, Huang Xinlei, Li Shimin, Zhang Li
Huazhong Agricultural University, Wuhan 430070, China.
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention; Chinese Center for Tropical Diseases Research, Shanghai 200001, China.
Infect Med (Beijing). 2024 Feb 21;3(1):100095. doi: 10.1016/j.imj.2024.100095. eCollection 2024 Mar.
The COVID-19 pandemic has created unprecedented challenges worldwide. Artificial intelligence (AI) technologies hold tremendous potential for tackling key aspects of pandemic management and response. In the present review, we discuss the tremendous possibilities of AI technology in addressing the global challenges posed by the COVID-19 pandemic. First, we outline the multiple impacts of the current pandemic on public health, the economy, and society. Next, we focus on the innovative applications of advanced AI technologies in key areas such as COVID-19 prediction, detection, control, and drug discovery for treatment. Specifically, AI-based predictive analytics models can use clinical, epidemiological, and omics data to forecast disease spread and patient outcomes. Additionally, deep neural networks enable rapid diagnosis through medical imaging. Intelligent systems can support risk assessment, decision-making, and social sensing, thereby improving epidemic control and public health policies. Furthermore, high-throughput virtual screening enables AI to accelerate the identification of therapeutic drug candidates and opportunities for drug repurposing. Finally, we discuss future research directions for AI technology in combating COVID-19, emphasizing the importance of interdisciplinary collaboration. Though promising, barriers related to model generalization, data quality, infrastructure readiness, and ethical risks must be addressed to fully translate these innovations into real-world impacts. Multidisciplinary collaboration engaging diverse expertise and stakeholders is imperative for developing robust, responsible, and human-centered AI solutions against COVID-19 and future public health emergencies.
新冠疫情在全球范围内带来了前所未有的挑战。人工智能(AI)技术在应对疫情管理和应对的关键方面具有巨大潜力。在本综述中,我们讨论了人工智能技术在应对新冠疫情带来的全球挑战方面的巨大可能性。首先,我们概述了当前疫情对公共卫生、经济和社会的多重影响。接下来,我们重点关注先进人工智能技术在新冠预测、检测、控制和治疗药物发现等关键领域的创新应用。具体而言,基于人工智能的预测分析模型可以利用临床、流行病学和组学数据来预测疾病传播和患者预后。此外,深度神经网络能够通过医学成像实现快速诊断。智能系统可以支持风险评估、决策制定和社会感知,从而改善疫情防控和公共卫生政策。此外,高通量虚拟筛选使人工智能能够加速治疗药物候选物的识别以及药物再利用的机会。最后,我们讨论了人工智能技术在抗击新冠疫情方面的未来研究方向,强调了跨学科合作的重要性。尽管前景广阔,但必须解决与模型泛化、数据质量、基础设施准备情况和伦理风险相关的障碍,以便将这些创新充分转化为实际影响。跨学科合作需要不同的专业知识和利益相关者参与,这对于开发强大、负责且以人为本的人工智能解决方案以应对新冠疫情和未来的突发公共卫生事件至关重要。
Infect Med (Beijing). 2024-2-21
Front Artif Intell. 2021-5-14
J Multidiscip Healthc. 2024-8-15
J Pers Med. 2021-9-4
World J Crit Care Med. 2025-9-9
Viruses. 2025-5-18
Infect Med (Beijing). 2024-11-9
Int J Health Plann Manage. 2025-1
Digit Health. 2024-10-3
Healthcare (Basel). 2024-8-26
Sci One Health. 2023-11-3
IEEE Trans Big Data. 2020-10-21
Nature. 2023-10